Dermatomyositis medical therapy: Difference between revisions
(Created page with "__NOTOC__ {{Dermatomyositis}} {{CMG}} ==Overview== ==Medical Therapy== There is no cure for dermatomyositis, but the symptoms can be treated. Options include medication, phys...") |
No edit summary |
||
| Line 11: | Line 11: | ||
Periodic treatment using intravenous immunoglobulin can also improve recovery. Other immunosuppressive agents used to treat the inflammation associated with dermatomyositis include [[cyclosporine A]], [[cyclophosphamide]], and [[tacrolimus]]. | Periodic treatment using intravenous immunoglobulin can also improve recovery. Other immunosuppressive agents used to treat the inflammation associated with dermatomyositis include [[cyclosporine A]], [[cyclophosphamide]], and [[tacrolimus]]. | ||
Physical therapy is usually recommended to prevent muscle atrophy and to regain muscle strength and range of motion. Many individuals with dermatomyositis may need a topical ointment, such as topical corticosteroids, for their skin disorder. They should wear a high-protection sunscreen and protective clothing. | Physical therapy is usually recommended to prevent muscle atrophy and to regain muscle strength and range of motion. Many individuals with dermatomyositis may need a topical ointment, such as topical corticosteroids, for their skin disorder. They should wear a high-protection sunscreen and protective clothing. | ||
# [[Prednisolone]] | |||
# [[Methotrexate]] | |||
# [[Mycophenolate]] (CellCept / Myfortic) | |||
# [[Intravenous immunoglobulin]] | |||
# [[Azathioprine]] | |||
# [[Cyclophosphamide]] | |||
# [[Rituximab]]<ref name="pmid16638371">{{cite journal | |||
|author=Scheinfeld N | |||
|title=A review of rituximab in cutaneous medicine | |||
|journal=Dermatol. Online J. | |||
|volume=12 | |||
|issue=1 | |||
|pages=3 | |||
|year=2006 | |||
|pmid=16638371 | |||
|doi= | |||
|url=http://dermatology.cdlib.org/121/reviews/rituxab/scheinfeld.html | |||
}}</ref> | |||
==References== | ==References== | ||
Revision as of 15:46, 30 October 2012
|
Dermatomyositis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dermatomyositis medical therapy On the Web |
|
American Roentgen Ray Society Images of Dermatomyositis medical therapy |
|
Risk calculators and risk factors for Dermatomyositis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
There is no cure for dermatomyositis, but the symptoms can be treated. Options include medication, physical therapy, exercise, heat therapy (including microwave and ultrasound), orthotics and assistive devices, and rest. The standard treatment for dermatomyositis is a corticosteroid drug, given either in pill form or intravenously.
Immunosuppressant drugs, such as azathioprine and methotrexate, may reduce inflammation in people who do not respond well to prednisone.
Periodic treatment using intravenous immunoglobulin can also improve recovery. Other immunosuppressive agents used to treat the inflammation associated with dermatomyositis include cyclosporine A, cyclophosphamide, and tacrolimus.
Physical therapy is usually recommended to prevent muscle atrophy and to regain muscle strength and range of motion. Many individuals with dermatomyositis may need a topical ointment, such as topical corticosteroids, for their skin disorder. They should wear a high-protection sunscreen and protective clothing.
- Prednisolone
- Methotrexate
- Mycophenolate (CellCept / Myfortic)
- Intravenous immunoglobulin
- Azathioprine
- Cyclophosphamide
- Rituximab[1]
References
- ↑ Scheinfeld N (2006). "A review of rituximab in cutaneous medicine". Dermatol. Online J. 12 (1): 3. PMID 16638371.